
GEMร Showcases High-Performance Solutions at FCE Pharma 2026
๐ฌ GEMUฬ leva solucฬงoฬes de alta performance aฬ FCE Pharma 2026! A GEMUฬ do Brasil reforcฬงa seu papel estrateฬgico na induฬstria farmaceฬutica latinoโamericana, apresentando tecnologias voltadas aฬ segurancฬงa, rastreabilidade e eficieฬncia operacional. Na FCE Pharma 2026, a empresa mostraraฬ vaฬlvulas asseฬpticas, solucฬงoฬes SingleโUse e sistemas de automacฬงaฬo que atendem aos mais altos padroฬes regulatoฬrios. ๐ O mercado brasileiro de medicamentos movimentou R$ 178 bi em 2023 โ e a inovacฬงaฬo eฬ o motor desse crescimento. ๐ Leia a mateฬria completa em www.doisamaisfarma.com.br e veja como a GEMUฬ estaฬ impulsionando o futuro da life science.
#pharma #lifeScience #businessdevelopment #procurement #growth #innovation #productmanagement #sales #marketing #tecnologia #lead #conversaฬo #employerbranding #talentattraction #people #cultura #rh
#pharma #lifeScience #businessdevelopment #procurement #growth #innovation #productmanagement #sales #marketing #tecnologia #lead #conversaฬo #employerbranding #talentattraction #people #cultura #rh
Shared byBlair Diaz - 10 days ago
Log in to comment
Loading ..
Related Articles
Expert Discussions and Innovations at the Pharmaceutical Water Event's Second Day
Join the XI Industrial Microbiology Symposium โ Shaping the Future of Industry
Exploring the Future of Digital Pharmacovigilance in Brazil: A Two-Day Event
Novartis Increases Clinical Research Investment in Brazil, Driving Global Health Innovation
Immerse in Digital and Strategic Pharmacovigilance in Brazil: FGV Event 2026
Digital and Strategic Pharmacovigilance Era in Brazil: An Immersive Event
18
0/100